首页> 美国政府科技报告 >Immunotherapy Targeting Tumor Stromal Fibroblasts Improves Chemotherapy of Breast Cancer
【24h】

Immunotherapy Targeting Tumor Stromal Fibroblasts Improves Chemotherapy of Breast Cancer

机译:靶向肿瘤基质成纤维细胞的免疫疗法改善了乳腺癌的化疗

获取原文

摘要

We demonstrated that a DNA-based vaccine encoding fibroblast activation protein (FAP), overexpressed on tumor-associated fibroblasts (TAFs), induces a CD8+ T cell response killing TAFs. This effectively suppressed or eradicated primary tumors or their pulmonary metastases in a murine breast carcinoma model. Moreover, eradication of TAFs decreased the interstitial fluid pressure of the tumor since it markedly diminished collagen type I produced by TAFs. This resulted in increased tumor uptake (70%) of doxorubicin which made the combination of the pFAP vaccine with chemotherapy highly effective as it completely eradicated primary breast tumor growth in a mouse tumor model.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号